chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a currently 56 year old female pharmacist with no drug reactions/allergies refers to herself. The patient's medical history included shingles in February of 2012 (exact date unspecified). There was no concomitant medication. The pharmacist reported that when she (the pharmacist) administers ZOSTAVAX to patients, she (the pharmacist) experienced reactivation of herpes and reactivation of shingles, about 7 to 10 days after administering ZOSTAVAX. The pharmacist reported that she had experienced reactivation of herpes about 6 times in the last two months and currently was experiencing reactivation of shingles (on her right hip). Lab diagnostics studies were not performed. The pharmacist did not seek medical attention. Valacyclovir hydrochloride was given as treatment for the event. The outcome of the event was not recovered. The pharmacist felt there was an association with the development of the herpes and the shingles and her (the pharmacist) administration of ZOSTAVAX to patients. The pharmacist never received a vaccination of ZOSTAVAX, but administered ZOSTAVAX to patients. Additional information has been requested.
Patient was given Pentacel and another HIB instead of a dose of hepatitis B vaccine.
Patient received Pfizer-BioNTech  vaccine as his 2nd dose when he should have received Moderna
pt c/o of pain in lt ear on 21OCT93; 23OCT93 AM upon waking, pt's lt eye would not close & lt side of mouth drawn; some paralysis/weakness; dx w/bell's Palsy;
Had tingling, hypertension, and hyperventilating 5 minutes after injection.  Was place on a table in a supine position.  BP was monitored and was down to 165/86 at 45 minutes after injection.   Heart rate = 67 O2 Stat = 100.  indicative of a vasovagal reaction.  Was able to leave clinic after 1 hour and did not work the rest of the day
Nausea, extreme fatigue, diarrhea, muscle/body aches, headache chills then burning up  all but headache lasted approx 48 hours, headache went for 5 days
Patient reported that she received her 2nd COVID vaccine. She reports no symptoms after her first vaccine injection. Both injections were in her left deltoid. On the evening of 2/2/2021, she started having some aching in the left arm. She noticed that her left axillary lymph node is swollen and painful. She states the swelling is very significant and it hurts, not just tender to touch. Doesn't look red or feel warm. No fever. She took ibuprofen 400 mg. Patient advised to follow-up with her PCP.
Sinus Pressure; Unproductive Cough; Random Fever; This spontaneous case was reported by a consumer and describes the occurrence of PARANASAL SINUS DISCOMFORT (Sinus Pressure), COUGH (Unproductive Cough) and PYREXIA (Random Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced PARANASAL SINUS DISCOMFORT (Sinus Pressure), COUGH (Unproductive Cough) and PYREXIA (Random Fever). At the time of the report, PARANASAL SINUS DISCOMFORT (Sinus Pressure), COUGH (Unproductive Cough) and PYREXIA (Random Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Starting 5 weeks after the second vaccine for covid, I began experiencing some mild nerve discomfort down my left arm, mostly from my elbow down through my pinky and ring finger on my left hand. Those two fingers would sometimes feel mildly tingly, almost numb. The most intense time of that feeling lasted for about 1-2 weeks, and then it slowly fade away until it was completely gone, I can't remember now exactly, but it lasted for about 8-12 weeks.  My right arm had a slight version (notably less) of some faint pain and numbness down my arm, and one faintly numb spot on my thumb. It started at the same time, but lasted only about a week. Because I experienced this in both arms, I'm not sure if it was related to the vaccine, because both my shots were in my left arm.  But I didn't have any other explanation for why this would suddenly happen.
UTI; due for her second dose for the vaccine on Friday 21; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI) and PRODUCT DOSE OMISSION ISSUE (due for her second dose for the vaccine on Friday 21) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (UTI) and PRODUCT DOSE OMISSION ISSUE (due for her second dose for the vaccine on Friday 21). At the time of the report, URINARY TRACT INFECTION (UTI) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (due for her second dose for the vaccine on Friday 21) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment for the event included antibiotics.    Reporter did not allow further contact
LPN diluted Covid vial with 1.3ml of saline instead of 2.3ml. Patient received 2nd dose as per CDC pt doesn't need a 3rd dose. Patient received a higher concentrated dose of covid vaccine, Patients is cover for all series until CDC updates any guidelines.    As pe rmom patient is stable no symptoms .
Injection site itchy; Soreness in arm; Redness at injection site; Swelling in injection site; Soreness in arm; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of the third episode of PAIN IN EXTREMITY (Soreness in arm), the second episode of PAIN IN EXTREMITY (Soreness in arm), the first episode of PAIN IN EXTREMITY (Soreness in arm), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling in injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hyperlipidemia.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced the first episode of PAIN IN EXTREMITY (Soreness in arm). On 05-Feb-2021, the patient experienced the second episode of PAIN IN EXTREMITY (Soreness in arm). On 06-Feb-2021, the patient experienced the third episode of PAIN IN EXTREMITY (Soreness in arm), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling in injection site). On 08-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itchy). At the time of the report, last episode of PAIN IN EXTREMITY (Soreness in arm), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (Swelling in injection site) and VACCINATION SITE PRURITUS (Injection site itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications reported were medicine for cholesterol, vitamin B12 injection once a month for  unknown indication.  Treatment details were not reported.   Reporter did not allow further contact
Information has been received from a physician concerning a 15 month old male with no allergies or past medical history who on 10/23/01 was vaccinated with varicella virus vaccine live (lot 635600/1248K). Concomitant therapy included MMR vaccine. On appropriately 05/28/02, the child developed chicken pox with more than 100 lesions on his face and body that were itchy and typical in appearance. The child also had one lesion on his right eye which resulted in a severe case of conjunctivitis. It was reported that the child was now being followed for cloudiness of his cornea. The child was seen in the office on 06/25/02 and his lesions were drying up. Upon internal review, the corneal haze was considered to be an other important medical event (OMIC). *F/UP report on 10/10/02: Additional info has been received from the MD. The MD reported that the child had developed chicken pox. He also reported that the child was seen in the office and he had 1 lesion on his eye, which resulted in conjunctivitis. The child was Dx'd w/varicella keratitis. The child has since recovered and was reported as doing fine. Add'l info. is not expected.*
4/15/03 Noticed "white spot" at vaccination site. 4/16/03 Developed pustule. Followed up with MD- "irritation" to site. 4/18/03 Seen in ER with brown drainage to site, 2 pustules noted.C/O muscle aches, fatigue, and headache. Treated with 1gm Rocephin and given script for Keflex 500 tid. 4/22/03 Contacted State Health Department and CDC- viral cultures x 3 and 2 slides obtained. 4/23/03 Biopsy to be obtained and sent to CDC for evaluation
Raised welt at injection site, redness that spread around site. Reaction within <5 mins of injection. Provider notified. .4mL BENADRYL PO given.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Had Covid-19 Virus, starting Oct 20.  Asked Primary Care Physician, Dr  for an exemption from getting vaccine, since just recovered from virus.  Was told to get vaccine, as new studies said that the best time to get the vaccine was just after quarantine period was over.  I followed his orders and had a heart attack 3 days later.  I had no prior heart or other health issues other than vertigo (9/25/21) and a removed appendix (in early 20's) before receiving this vaccine.  95% blood clot to the left primary artery.  To further explain:  My employer was requiring the Pfizer vaccine by Nov 3.  I had just returned to work Nov 1, after having Covid-19.  I called Dr   Nov 2 to request a 60-90 day exemption, as the  Clinic had published a report recommending waiting that long after having the virus before getting the vaccine.  He refused to give the exemption.  It was his opinion that it would be best for me to go ahead and get the vaccine.  The  Clinic even had warnings about receiving the vaccine within 14 days of a Covid 19 diagnosis.  When I told them about having just gotten past my quarantine, they asked what my doctor said.  After I told them, they gave me the shot.  Up until September 25 of this year, the only major medical I have ever experienced was having my appendix removed in my early 20's.  On September 25, I went to the emergency room  and was diagnosed with Vertigo (BPPV).  At that time, my blood pressure and all my vital signs were completely normal.  There has never been any heart related health concern prior.  The CICU doctors cannot tell me what level of plaque I did have prior to the heart attack, only that the heart attack was caused because after the plaque ruptured the blood clotted in the left primary artery 95%.  There are no signs that the plaque levels are above 20% anywhere else which CDC says is normal for a male my age.
Neurological side effects; Progressive left arm weakness; Spasms; Symptoms worsen over several months; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (unknown if pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NEUROLOGICAL SYMPTOM (non-serious), outcome "unknown", described as "Neurological side effects"; MUSCULAR WEAKNESS (non-serious), outcome "unknown", described as "Progressive left arm weakness"; MUSCLE SPASMS (non-serious), outcome "unknown", described as "Spasms"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "Symptoms worsen over several months". It was unknown if therapeutic measures were taken as a result of neurological symptom, muscular weakness, muscle spasms, condition aggravated.  Clinical course was the following: It was reported about an incidence after the initial 2 doses of Pfizer- BioNTech COVID-19 Vaccine. She noted she had neurological side effects. The symptoms were delayed so she is not sure was it from the vaccine. She had progressive left arm weakness, then spasms, trouble lifting a fork as it will hit the face, and trouble typing. Symptoms worsen over several months and slowly subsided over the summer. She said it is probably not related to the vaccine but these issues only occurred in the vaccinated arm. Symptoms seemed worse in the cold and improved in the warmer temperatures. Symptoms did not return this winter. Then, the patient received the third dose (Moderna vaccine).  The lot number for bnt162b2 was not provided and will be requested during follow up.
Alot of pain; Swollen arm; Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Alot of pain), PERIPHERAL SWELLING (Swollen arm) and LYMPHADENOPATHY (Swollen lymph nodes) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 027C21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and ATORVASTATIN for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced PAIN (Alot of pain), PERIPHERAL SWELLING (Swollen arm) and LYMPHADENOPATHY (Swollen lymph nodes). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Apr-2021, PERIPHERAL SWELLING (Swollen arm) and LYMPHADENOPATHY (Swollen lymph nodes) had resolved. At the time of the report, PAIN (Alot of pain) had not resolved.            Pain is still ongoing and getting worse.
Hot flashes & night sweats started 6/11 and continued 7/1 25-30 a day.  Was suppose to start period 6/11. (Last period start date was May 15) never started in June. Went to family doctor 7/7 she ran blood work. Received my blood work back with a call that my Follicle Stimulating Hormone was 27.7 and that I was on menopause.  The next day after receiving the call I started.
Muscle spasms on side of injection in neck and face; This is a spontaneous report from a non-contactable consumer (patient). A 30-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration in left arm on 10Apr2021 (at the age of 30-years-old) at 14.15 at single dose for COVID-19 immunization. The patient medical history and concomitant medication were not reported. The patient had no known allergies including allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior and was not pregnant. The patient had not been tested for COVID-19 since the vaccination. The patient experienced muscle spasms on side of injection in neck and face on 11Apr2021. The event was reported as non-serious. No treatment was received for the event. The patient was recovering the event.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Approximately three and a half inch red, hot to touch, raised rash on her left arm where her injection site was. Was itchy and painful, but improving. Started evening 24+ hours after vaccine administered.
Pain and redness at injection site 8 days after vaccine. Lasted for days 8, 9, and half of 10.
Extreme intermittent pains shooting in my joints seems like intense burning in joints and bones,  all the time, bounces around but most in fingers, arms, feet, and chest/ribs
Felt unwell; pretty out of it; fever; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (Felt unwell), FEELING ABNORMAL (pretty out of it) and PYREXIA (fever) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Epilepsy and Immunocompromised (Immunocompromised with neutropenia low white blood cell count.). Concomitant products included LEVETIRACETAM and ZONISAMIDE for Epilepsy.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt unwell), FEELING ABNORMAL (pretty out of it) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Fever, at an unspecified dose and frequency. At the time of the report, MALAISE (Felt unwell), FEELING ABNORMAL (pretty out of it) and PYREXIA (fever) outcome was unknown.            This case was linked to MOD-2022-667347 (Patient Link).
mom c/o knot in child lower rt thigh;advised mom to keep cool compresses on legs 3-4times a day;HIB vax given in lower rt thigh;
PT C/O rapid pulse, shakiness, dry mouth, and difficulty swallowing. Pt stated symptoms occurred 15 minutes after this nurse left from completing 15 minutes monitoring. Pt was given a one time IM injection of solumedrol 125mg. Pt was monitored for 30 minutes, which at this time pt stated he still had dry mouth but swallowing had returned to normal. Pulse was rechecked for a final time, which the rate had returned to 95.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe
This is a spontaneous report received from a contactable consumer (patient's friend). A 40-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# unknown), via an unknown route of administration, on Mar 6, 2021, single dose, for COVID-19 immunization. The patient's medical history and concomitant medication not reported. On Mar 6 ,2021, patient experienced hives and rashes. The patient will be getting her second dose. The outcome of events unknown. No follow-up attempts needed. Information about lot/batch number cannot be obtained.
This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.  No Medical History information was reported.On 22-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 22-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that expiration date of the vaccine was on 29-Sep-2021. No concomitant medications were reported.No treatment information were reported.
Tongue swelling, nonproductive cough, wheezing, chest tightness, SOB, palpitations. Hives body (chest/arms/legs) & red face, runny nose. Called 911, took BENADRYL & seen Emergency Dept.
Hives have persisted for 9 weeks + , itchy, red, raised hives.  Hives are located all over body.  I went and saw an allergist.  The only course of action I can take is to continue to take antihistamines.  I take antihistamines everyday which helps the hives go away.
Had Covid Vaccine today and was monitored  and cleared. Today, after lunch about 1:30 pm began experiencing itching to his head and upper chest. Came back to the clinic. Denies wheezing, trouble breathing or tongue being swollen. Says that he has bumps on his head. Assessed to have hives on head and a few scattered on neck and chest and one on abdomen. Seen by Dr.. No tongue swelling, no SOB, no throat tightening, nausea or abd pain. Vital signs: initial BP 166/89, P 81, RR 18. VS on DC: BP 135/82, P 65 RR 14 T 98.20 O2 Sat 95%. Refused benadryl as he was driving and didn't want to drive while sleepy. Given Famotidine, which resolved his hives and itching.
Acute disseminated encephalomyelitis (ADEM); Initial information was received on 11-Feb-2021 regarding an unsolicited valid serious case received from a consumer or non-health care professional via media.  This case involves a male patient (exact age unknown) who experienced acute disseminated encephalomyelitis, while he received vaccine INFLUENZA VACCINE.  The patient's past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided. It was unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed serious acute disseminated encephalomyelitis (ADEM) (acute disseminated encephalomyelitis) (Unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  It was unknown if the patient experienced any additional symptoms/events.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  Information on the batch number was requested.  Medication details and reason for taking the medicine: Product name was not provided. Since this was a public comment it was assumed that the consumer was referring to the Sanofi flu vaccine.; Sender's Comments: This case involves a male-patient (exact age unknown) who experienced acute disseminated encephalomyelitis after vaccination with INFLUENZA VACCINE. The time to onset is unknown. Further information regarding medical history, concurrent condition during vaccination, previous vaccination and tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
Pt devel shingles approx 30 days p/receiving influenza vax;